BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19216231)

  • 1. Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol.
    Choi JS; Choi BC; Kang KW
    Pharmazie; 2009 Jan; 64(1):49-52. PubMed ID: 19216231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of morin on the pharmacokinetics of nicardipine after oral and intravenous administration of nicardipine in rats.
    Piao YJ; Choi JS
    J Pharm Pharmacol; 2008 May; 60(5):625-9. PubMed ID: 18416939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats.
    Choi JS; Burm JP
    Arch Pharm Res; 2009 Dec; 32(12):1721-5. PubMed ID: 20162400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.
    Choi JS; Koh YY; Chung JH; Choi DH; Han HK
    J Pharm Pharmacol; 2008 Oct; 60(10):1403-7. PubMed ID: 18812034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of curcumin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen, in rats: possible role of CYP3A4 and P-glycoprotein inhibition by curcumin.
    Cho YA; Lee W; Choi JS
    Pharmazie; 2012 Feb; 67(2):124-30. PubMed ID: 22512082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of silybinin, CYP3A4 and P-glycoprotein inhibitor in vitro, on the bioavailability of loratadine in rats.
    Li C; Lee MY; Choi JS
    Pharmazie; 2010 Jul; 65(7):510-4. PubMed ID: 20662320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of baicalein, an antioxidant, on the bioavailability of doxorubicin in rats: possible role of P-glycoprotein inhibition by baicalein.
    Shin SC; Li C; Choi JS
    Pharmazie; 2009 Sep; 64(9):579-83. PubMed ID: 19827298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
    Hong SP; Choi DH; Choi JS
    Cardiovasc Ther; 2008; 26(4):269-75. PubMed ID: 19035878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X; Choi JS
    Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
    Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morin on the pharmacokinetics of etoposide in rats.
    Li X; Yun JK; Choi JS
    Biopharm Drug Dispos; 2007 Apr; 28(3):151-6. PubMed ID: 17315145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
    Lee CK; Choi JS
    Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved effectiveness of biochanin A as a P-gp inhibitor in solid dispersion.
    Han HK; Lee HK
    Pharmazie; 2011 Sep; 66(9):710-5. PubMed ID: 22026129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein.
    Cho YA; Choi JS; Burm JP
    Pharmacol Rep; 2011; 63(4):1066-73. PubMed ID: 22001996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of myricetin on the bioavailability of carvedilol in rats.
    Lee W; Woo ER; Choi JS
    Pharm Biol; 2012 Apr; 50(4):516-22. PubMed ID: 22132944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lovastatin on the pharmacokinetics of nicardipine in rats.
    Chung JW; Yang SH; Choi JS
    Biopharm Drug Dispos; 2010 Oct; 31(7):436-41. PubMed ID: 20824619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of licochalcon A on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats.
    Choi JS; Choi JS; Choi DH
    Pharmazie; 2013 Nov; 68(11):882-8. PubMed ID: 24380237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C; Li X; Choi JS
    Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
    Chung JH; Choi DH; Choi JS
    Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.